Date published: 2026-3-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

EBF3 Inhibitors

The Early B-cell Factor 3 (EBF3) protein emerges as a key player in cellular processes, intricately involved in the regulation of transcriptional programs governing cellular differentiation and tissue development. As a member of the EBF family of transcription factors, EBF3 plays a crucial role in orchestrating cellular responses, particularly in the context of B-cell development and neuronal differentiation. Functionally, EBF3 acts as a transcriptional regulator, binding to specific DNA sequences and modulating the expression of target genes essential for cellular differentiation and lineage commitment. In the context of B-cell development, EBF3 contributes to the specification and commitment of B-cell lineages, influencing critical cellular processes such as immunoglobulin gene rearrangement and maturation. Additionally, EBF3 has been implicated in neuronal differentiation, where it participates in the transcriptional regulation of genes involved in neurogenesis and synaptic function. The multifaceted role of EBF3 in diverse cellular contexts underscores its significance in maintaining cellular identity and orchestrating complex developmental programs. The inhibition of EBF3 function, whether through direct inhibition or indirect interference with associated signaling pathways, provides a valuable avenue for exploring the intricate regulatory mechanisms governing cellular differentiation. The presented inhibitors target various signaling cascades, such as ERK5/MAPK7, B-cell receptor (BCR), TGF-β/Smad, and PI3K/Akt, which intersect with EBF3 signaling. Additionally, inhibitors affecting chromatin accessibility, such as BET inhibitors like JQ1 and histone methyltransferase inhibitors like BIX 01294, shed light on the epigenetic control of EBF3-mediated transcriptional programs. Understanding the molecular intricacies of EBF3 inhibition allows researchers to unravel the complex network of interactions influencing cellular fate determination and tissue development. The modulation of EBF3 provides insights into the regulatory mechanisms governing cellular differentiation, offering a foundation for further research into the fundamental processes that dictate cell identity and function.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

BAY 61-3606

sc-507485
2 mg
$345.00
1
(0)

Selective Syk kinase inhibitor. By inhibiting Syk, a protein involved in B-cell receptor signaling, BAY 61-3606 disrupts the BCR pathway, which intersects with EBF3 function.

SIS3 hydrochloride

521984-48-5sc-253565
5 mg
$334.00
2
(1)

Inhibitor of Smad3 phosphorylation, targeting the TGF-β/Smad signaling pathway. Blocking Smad3 phosphorylation disrupts the TGF-β pathway, which crosstalks with EBF3 regulation.

PP 2

172889-27-9sc-202769
sc-202769A
1 mg
5 mg
$94.00
$227.00
30
(1)

Src family kinase inhibitor. PP2 inhibits Src, a kinase involved in various signaling pathways, including those intersecting with EBF3 function.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$231.00
$863.00
1
(0)

Bromodomain and extraterminal (BET) family inhibitor. By targeting BET proteins, including BRD4, JQ1 influences chromatin accessibility and gene expression.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

MEK inhibitor targeting the MAPK/ERK pathway. Inhibiting MEK disrupts the MAPK/ERK pathway, which cross-talks with EBF3 signaling.

Histone Lysine Methyltransferase Inhibitor Inhibitor

935693-62-2 (free base)sc-202651
5 mg
$151.00
4
(1)

G9a histone methyltransferase inhibitor. By blocking G9a, BIX 01294 alters the epigenetic landscape, impacting EBF3 transcriptional regulation.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Irreversible PI3K inhibitor. Inhibiting PI3K disrupts the PI3K/Akt pathway, which crosstalks with EBF3 signaling.

Tyrphostin B42

133550-30-8sc-3556
5 mg
$26.00
4
(1)

Tyrosine kinase inhibitor targeting JAK2. By inhibiting JAK2, AG490 disrupts the JAK/STAT pathway, which intersects with EBF3 function.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Anthrapyrazolone compound. Inhibitor of JNK, a kinase involved in various cellular processes. By blocking JNK activity, SP600125 indirectly affects EBF3, as JNK can regulate EBF3 expression and activity in specific cellular contexts.